Skip to main content

Advertisement

Log in

Follicular thyroid carcinoma

  • Published:
Current Treatment Options in Oncology Aims and scope Submit manuscript

Opinion statement

Follicular carcinomas are rare thyroid malignancies that are difficult to diagnose preoperatively. Fine needle aspiration is an excellent diagnostic tool and should be the initial step in managing the solitary thyroid nodule. Follicular carcinoma cannot be diagnosed with certainty by cytologic features alone; the diagnosis rests on the histologic findings of blood vessel or tumor capsule invasion. Surgical resection is the primary option for treatment. The extent of thyroidectomy for optimal survival outcome has not been determined scientifically. The outcome is excellent in minimally invasive follicular carcinoma with lobectomy and isthmusectomy; it is difficult to argue that total thyroidectomy is necessary. In a low risk prognostic group, for tumors other than minimally invasive carcinoma, lobectomy and isthmusectomy or total thyroidectomy can be justified. However, if total thyroidectomy can be done safely with a minimum of complications, then it has definite advantages for staging, postoperative surveillance, treatment, and possibly a lower recurrence rate and better survival rate. For all patients at high risk of recurrence, total thyroidectomy is preferred.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Ontario Cancer Registry: Thyroid gland. Cancer Care Ontario, 1999. www.cancercare.on.ca.

  2. Hundahl SA, Fleming ID, Fremgen AM, Menck HR: A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S. 1985–1995. Cancer 1998, 83:2638–2648.

    Article  PubMed  CAS  Google Scholar 

  3. Pettersson B, Adami HO, Wilander E, Coleman MP: Trends in thyroid cancer incidence in Sweden, 1958–1981, by histopathologic type. Int J Cancer 1991, 48:28–33.

    Article  PubMed  CAS  Google Scholar 

  4. Pettersson B, Coleman MP, Ron E, Adami HO: Iodine supplementation in Sweden and regional trends in thyroid cancer incidence by histopathologic type. Int J Cancer 1996, 65:13–19.

    Article  PubMed  CAS  Google Scholar 

  5. Mazzaferri EL, Jhiang SM: Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994, 97:418–4428.

    Article  PubMed  CAS  Google Scholar 

  6. Sherman SI, Brierley JD, Sperling M, et al.: Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome. Cancer 1998, 83:1012–1021.

    Article  PubMed  CAS  Google Scholar 

  7. Doherty GM: Follicular neoplasms of the thyroid. In Textbook of Endocrine Surgery. Edited by Clark OH, Duh Q-Y. Philadelphia: WB Saunders; 1997:95–102.

    Google Scholar 

  8. Livolsi VA, Asa SL: The demise of follicular carcinoma of the thyroid gland. Thyroid 1994, 4:233–236.

    PubMed  CAS  Google Scholar 

  9. McHenry CR, Raeburn C, Strickland T, Marty JJ: The utility of routine frozen section examination for intraoperative diagnosis of thyroid cancer. Am J Surg 1996, 172:658–661.

    Article  PubMed  CAS  Google Scholar 

  10. Chen H, Nicol TL, Udelsman R: Follicular lesions of the thyroid: does frozen section evaluation alter operative management? Ann Surg 1995, 222:101–106.

    Article  PubMed  CAS  Google Scholar 

  11. Emerick GT, Duh Q-Y, Siperstein AE, et al.: Diagnosis, treatment, and outcome of follicular thyroid carcinoma. Cancer 1993, 72:3287–3295.

    Article  PubMed  CAS  Google Scholar 

  12. Rosai J, Carcangiu ML, DeLellis RA: Follicular carcinoma. In Tumors of the Thyroid Gland, third series. Edited by Rosai J, Carcangiu ML, DeLellis RA. Washington, DC: Armed Forces Institute of Pathology; 1992:49–64.

    Google Scholar 

  13. Thompson LDR, Wieneke JA, Paal E, et al.: A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature. Cancer 2001, 91:505–524.

    Article  PubMed  CAS  Google Scholar 

  14. Hay ID, Grant CS, Taylor WF, McConahey WM:Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987, 102:1171–1178.

    Google Scholar 

  15. Hay ID, Bergstrahl EJ, Goellner J, et al.: Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993, 114:1050–1057.

    PubMed  CAS  Google Scholar 

  16. Byar DP, Green SB, Dor P, et al.: A prognostic index for thyroid carcinoma: a study of the EORTC Thyroid Cancer Cooperative Group. Eur J Cancer 1979, 15:1033–1041.

    PubMed  CAS  Google Scholar 

  17. Cady B, Rossi R: An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988, 104:947–953.

    PubMed  CAS  Google Scholar 

  18. Shaha AR, Loree TR, Shah JP: Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 1995, 118:1131–1138.

    Article  PubMed  CAS  Google Scholar 

  19. Thyroid gland. In AJCC Cancer Staging Handbook, edn 5. Edited by Fleming ID, Cooper JS, Henson DE, et al. Philadelphia: Lippincott-Raven; 1998:61-64.

  20. van Heerden JA, Hay ID, Goellner JR, et al.: Follicular thyroid carcinoma with capsular invasion alone: a non-threatening malignancy. Surgery 1992, 112:1130–1136.

    Google Scholar 

  21. McHenry CR, Sandoval B: Management of follicular and Hurthle cell neoplasms of the thyroid gland. Surg Oncol Clin North Am 1998, 7:893–910.

    CAS  Google Scholar 

  22. Ozata M, Suzuki S, Miyamoto T, et al.: Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer. J Clin Endocrinol Metab 1994, 79:98–105.

    Article  PubMed  CAS  Google Scholar 

  23. Cooper DS, Specker B, Ho M, et al.: Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid 1998, 8:737–744.

    Article  PubMed  CAS  Google Scholar 

  24. Quan ML, Pasieka JL, Rorstad O: Bone mineral density in well-differentiated thyroid cancer patients treated with suppressive thyroxine: a systematic overview of the literature. J Surg Oncol 2002, 79:62–69.

    Article  PubMed  CAS  Google Scholar 

  25. Taylor T, Specker B, Robbins J, et al.: Outcome after treatment of high-risk papillary and non-Hurthle-cell follicular thyroid carcinoma. Ann Intern Med 1998, 129:622–627.

    PubMed  CAS  Google Scholar 

  26. Johansen K, Woodhouse NJ, Odugbesan O: Comparison of 1073 MBq and 3700 MBq iodine-131 in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid cancer. J Nucl Med 1991, 32:252–254.

    PubMed  CAS  Google Scholar 

  27. Muratet JP, Daver A, Minier JF, Larra F: Influence of scanning doses of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinoma. J Nucl Med 1998, 39:1546–1550.

    PubMed  CAS  Google Scholar 

  28. Haugen BR, Pacini F, Reiners C, et al.: A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 1999, 84:3877–3885.

    Article  PubMed  CAS  Google Scholar 

  29. Simpson WJ, Panzarella T, Carruthers JS, et al.:Papillary and follicular thyroid cancer: impact of treatment in 1578 patients. Int J Radiat Oncol Biol Phys 1988, 14:1063–1075.

    PubMed  CAS  Google Scholar 

  30. Tubiana M, Haddad E, Schlumberger M, et al.:External radiotherapy in thyroid cancers. Cancer 1985, 55:2062–2071.

    Article  PubMed  CAS  Google Scholar 

  31. Benker G, Olbricht T, Reinwein D, et al.: Survival rates in patients with differentiated thyroid carcinoma: influence of postoperative external radiotherapy. Cancer 1990, 65:1517–1520.

    Article  PubMed  CAS  Google Scholar 

  32. Samaan NA, Schultz PN, Hickey RC, et al.: The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab 1992, 75:714–720.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haigh, P.I. Follicular thyroid carcinoma. Curr. Treat. Options in Oncol. 3, 349–354 (2002). https://doi.org/10.1007/s11864-002-0034-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11864-002-0034-z

Keywords

Navigation